Hepatitis B more than ever holds a prominent position among the most notorious infectious diseases on a global scale and remains an actual threat to the world population. However, not all countries or continents are equally affected. Sub-Saharan Africa for example is a high-endemic region, with carrier rates of hepatitis B surface antigen (HBsAg) 8% among certain population groups, representing a significant burden to the health and development of a number of societies.